Charles Schwab’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,355
| Closed | -$218K | – | 3589 |
|
|
2025
Q1 | $218K | Buy |
67,355
+8,918
| +15% | +$30.7K | ﹤0.01% | 3245 |
|
|
2024
Q4 | $231K | Hold |
58,437
| – | – | ﹤0.01% | 3300 |
|
|
2024
Q3 | $452K | Buy |
58,437
+4,298
| +8% | +$28.2K | ﹤0.01% | 3188 |
|
|
2024
Q2 | $278K | Buy |
54,139
+43,662
| +417% | +$337K | ﹤0.01% | 3383 |
|
|
2024
Q1 | $85.2K | Hold |
10,477
| – | – | ﹤0.01% | 3322 |
|
|
2023
Q4 | $41.9K | Hold |
10,477
| – | – | ﹤0.01% | 3419 |
|
|
2023
Q3 | $43.2K | Hold |
10,477
| – | – | ﹤0.01% | 3418 |
|
|
2023
Q2 | $62.2K | Hold |
10,477
| – | – | ﹤0.01% | 3392 |
|
|
2023
Q1 | $36.1K | Hold |
10,477
| – | – | ﹤0.01% | 3408 |
|
|
2022
Q4 | $36.8K | Hold |
10,477
| – | – | ﹤0.01% | 3420 |
|
|
2022
Q3 | $38K | Hold |
10,477
| – | – | ﹤0.01% | 3396 |
|
|
2022
Q2 | $59K | Sell |
10,477
-34,216
| -77% | -$230K | ﹤0.01% | 3373 |
|
|
2022
Q1 | $387K | Buy |
44,693
+6,085
| +16% | +$61K | ﹤0.01% | 3154 |
|
|
2021
Q4 | $430K | Hold |
38,608
| – | – | ﹤0.01% | 3192 |
|
|
2021
Q3 | $500K | Buy |
38,608
+1,856
| +5% | +$29.6K | ﹤0.01% | 3151 |
|
|
2021
Q2 | $609K | Hold |
36,752
| – | – | ﹤0.01% | 3105 |
|
|
2021
Q1 | $632K | Buy |
36,752
+1,751
| +5% | +$32.7K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $548K | Hold |
35,001
| – | – | ﹤0.01% | 2960 |
|
|
2020
Q3 | $669K | Sell |
35,001
-1,086
| -3% | -$18.7K | ﹤0.01% | 2799 |
|
|
2020
Q2 | $495K | Buy |
36,087
+2,974
| +9% | +$41.8K | ﹤0.01% | 2833 |
|
|
2020
Q1 | $352K | Sell |
33,113
-17,828
| -35% | -$290K | ﹤0.01% | 2824 |
|
|
2019
Q4 | $951K | Buy |
50,941
+5,176
| +11% | +$66.6K | ﹤0.01% | 2614 |
|
|
2019
Q3 | $479K | Buy |
45,765
+5,033
| +12% | +$41K | ﹤0.01% | 2819 |
|
|
2019
Q2 | $309K | Buy |
+40,732
| New | +$354K | ﹤0.01% | 2995 |
|
|
2018
Q3 | – | Sell |
-50,476
| Closed | -$227K | – | 3139 |
|
|
2018
Q2 | $227K | Sell |
50,476
-37,633
| -43% | -$170K | ﹤0.01% | 3047 |
|
|
2018
Q1 | $472K | Buy |
88,109
+2,691
| +3% | +$12.4K | ﹤0.01% | 2748 |
|
|
2017
Q4 | $337K | Buy |
85,418
+3,588
| +4% | +$15.1K | ﹤0.01% | 2839 |
|
|
2017
Q3 | $358K | Buy |
81,830
+44,447
| +119% | +$210K | ﹤0.01% | 2816 |
|
|
2017
Q2 | $176K | Sell |
37,383
-26,820
| -42% | -$257K | ﹤0.01% | 3050 |
|
|
2017
Q1 | $1.06M | Buy |
64,203
+3,762
| +6% | +$49.2K | ﹤0.01% | 2407 |
|
|
2016
Q4 | $612K | Buy |
60,441
+3,388
| +6% | +$45.1K | ﹤0.01% | 2585 |
|
|
2016
Q3 | $768K | Buy |
57,053
+20,705
| +57% | +$304K | ﹤0.01% | 2471 |
|
|
2016
Q2 | $761K | Buy |
36,348
+21,994
| +153% | +$317K | ﹤0.01% | 2439 |
|
|
2016
Q1 | $136K | Buy |
14,354
+357
| +3% | +$2.96K | ﹤0.01% | 2954 |
|
|
2015
Q4 | $153K | Buy |
13,997
+455
| +3% | +$5.81K | ﹤0.01% | 3006 |
|
|
2015
Q3 | $203K | Buy |
+13,542
| New | +$237K | ﹤0.01% | 2954 |
|
Other funds holding XBIT
RC
Charles Schwab's XBIT Position: Q2 2025 in Review
Charles Schwab sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 67,355 shares — an estimated $218K sold.
Charles Schwab first reported a position in XBIT in Q3 2015 and held it in 36 quarters. The position peaked at $1.06M in Q1 2017. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.
- Charles Schwab reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
- Charles Schwab sold 67,355 XBiotech shares in Q2 2025, an estimated $218K.
- Charles Schwab first reported a position in XBiotech in Q3 2015 and held it in 36 quarters.
- Charles Schwab's XBiotech position peaked at $1.06M in Q1 2017.
- 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.